Clarity Health & Aesthetics

Clarity Health & Aesthetics operates as a direct primary care and integrative medicine practice in Kansas City, Missouri, where Dr. James McDonald combines membership-based primary care with peptide therapy, medical weight loss, and aesthetic treatments. The clinic's direct primary care model eliminates insurance billing complexities, allowing extended appointment times and direct provider access for patients managing chronic conditions alongside preventive wellness goals. This structure supports the integration of peptide protocols and IV nutrition into comprehensive care plans rather than treating them as isolated interventions.

The clinic administers NAD+ therapy through both IV infusions and injectable peptide formulations, targeting cellular energy production and metabolic optimization for patients experiencing fatigue, cognitive decline, or age-related metabolic changes. Semaglutide peptide therapy anchors the medical weight loss program, prescribed with metabolic assessment, body composition analysis, and nutrition counseling rather than as standalone medication. Dr. McDonald adjusts Semaglutide dosing based on individual response patterns and combines peptide treatment with dietary modification protocols specific to each patient's metabolic profile and weight loss resistance factors. The IV nutrition protocols deliver customized micronutrient combinations addressing deficiencies identified through laboratory testing, supporting both acute wellness needs and chronic condition management.

Dr. James McDonald brings direct primary care experience to the practice, maintaining ongoing relationships with patients that allow peptide therapy monitoring within the context of complete medical histories and existing conditions. His approach involves baseline laboratory evaluation before initiating NAD+ or Semaglutide protocols, with follow-up testing to track biomarker changes and treatment response. The integrative medicine framework means peptide therapies are considered alongside conventional treatments, lifestyle modifications, and nutritional interventions rather than positioned as replacements for standard medical care. Patients receive education on peptide mechanisms, expected timelines for clinical effects, and potential interactions with existing medications during initial consultations.

Patients visiting the Kansas City location for peptide consultations undergo medical history review, current medication assessment, and discussion of treatment goals before any therapy initiation. NAD+ protocols typically begin with loading doses administered via IV over 2-4 hour sessions, with patients monitored for tolerance and immediate response. Semaglutide weight loss patients receive injection training, weekly or bi-weekly dosing schedules, and structured follow-up appointments to assess weight trends, side effect management, and program adherence. The clinic schedules peptide therapy patients for regular check-ins rather than one-time treatments, recognizing that optimal results require dose adjustments and protocol modifications based on individual response patterns. Aesthetic services including facial treatments operate alongside medical services, allowing patients to address both wellness and cosmetic goals within a single practice relationship.

Clarity Health & Aesthetics differentiates itself through the direct primary care membership structure, which provides peptide therapy patients with enhanced access to Dr. McDonald between scheduled appointments via phone and secure messaging. This access model supports real-time troubleshooting of side effects, dosing questions, and treatment concerns that commonly arise during peptide protocols. The Kansas City practice maintains in-person consultation and treatment requirements, with all NAD+ infusions, Semaglutide injections, and initial assessments conducted at the clinic location rather than through telehealth platforms. Patients combining primary care membership with peptide treatments benefit from longitudinal care relationships where treatment decisions account for complete medical context rather than isolated symptom management.